On June 28, the First Asia Industrial Hemp Summit Forum 2019 co-hosted by CBDG Fund and Arcview was held in Hong Kong. At the forum, the experts of industrial hemp industry from the countries all over the world have made in-depth discussions on many topics including the application of cannabinoids in medicine and consumption, current situation of domestic and foreign investments in industrial hemp as well as the interpretation of global industrial hemp laws and regulations, and jointly looked forward to the huge market value space of in industrial hemp industry.
Shunho Stock was invited to attend the forum in Hong Kong, signed a strategic cooperation framework agreement with Unity Fund and CBDG Fund for joint investment in the all-media platform “Hemp Era” at the summit meeting, by which three parties will jointly incubate and actively promote the rapid development of the industrial hemp all-media platform “Hemp Era” in Asia, facilitate more sufficient exchanges of industry information and enhance their more mature and rational understanding about the industrial hemp market.
Yunnan Luxin Biologicial Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Shunho Stock, has specialized in cultivation and processing of industrial hemp, as well as the sales of its products. At the beginning of 2019, it obtained the Cultivation Permit and the written reply of processing license. The strategic investment of Shunho Stock will further improve its whole industry chain layout planning in industrial hemp field. It is believed that, with the development and expansion of industry media as well as the expansion and enriching of exchange activities, the huge value prospect of industrial hemp industry will be gradually realized.
